Single-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescents. [electronic resource]
Producer: 20120716Description: 395-8 p. digitalISSN:- 1476-5365
- Adolescent
- Canada
- Child
- Drug Resistance, Neoplasm
- Female
- Hodgkin Disease -- drug therapy
- Humans
- Lymphoma -- therapy
- Male
- Melphalan -- administration & dosage
- Myeloablative Agonists -- administration & dosage
- Recurrence
- Retrospective Studies
- Stem Cell Transplantation -- methods
- Transplantation Conditioning -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.